` 688185 (CanSino Biologics Inc) vs Shanghai Composite Comparison - Alpha Spread

688185
vs
Shanghai Composite

Over the past 12 months, has outperformed Shanghai Composite, delivering a return of 27% compared to the Shanghai Composite's 10% growth.

Stocks Performance
688185 vs Shanghai Composite

Loading
688185
Shanghai Composite
Add Stock

Performance Gap
688185 vs Shanghai Composite

Loading
688185
Shanghai Composite
Difference

Performance By Year
688185 vs Shanghai Composite

Loading
688185
Shanghai Composite
Add Stock

Competitors Performance
CanSino Biologics Inc vs Peers

Shanghai Composite
688185
LLY
JNJ
NOVO B
ROG
Add Stock

CanSino Biologics Inc
Glance View

Market Cap
10.1B CNY
Industry
Pharmaceuticals

CanSino Biologics Inc is a CN-based company operating in Pharmaceuticals industry. The company is headquartered in Tianjin, Tianjin and currently employs 1,946 full-time employees. The company went IPO on 2019-03-28. CanSino Biologics Inc is a clinical-stage vaccine company in China. The firm's products include Ad5-EBOV vaccine used for Ebola virus, MCV2 and MCV4 vaccines for meningococcus, PBPV vaccine used for pneumococcal and the recombinant novel coronavirus vaccine. Its products are mainly used in meningitis, diphtheria pertussis tetanus (DPT) and pneumonia.

Intrinsic Value
63.72 CNY
Undervaluation 3%
Intrinsic Value
Price
Back to Top